Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
6.57M
-
Shares change
-
+410K
-
Total reported value, excl. options
-
$62.8M
-
Value change
-
+$3.95M
-
Number of buys
-
30
-
Number of sells
-
-7
-
Price
-
$9.56
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q2 2020
46 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q2 2020.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.57M shares
of 13.8M outstanding shares and own 47.49% of the company stock.
Largest 10 shareholders include Battery Partners IX, LLC (2.42M shares), NEA Management Company, LLC (1.71M shares), BlackRock Inc. (436K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (252K shares), Cadence Capital Management LLC (232K shares), RENAISSANCE TECHNOLOGIES LLC (213K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (170K shares), DIMENSIONAL FUND ADVISORS LP (134K shares), OVERBROOK MANAGEMENT CORP (115K shares), and BANK OF MONTREAL /CAN/ (104K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.